Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study
Andrés Acosta, Michael Camilleri, Duane D. Burton, et al.
Physiological Reports (2015) Vol. 3, Iss. 11, pp. e12610-e12610
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
Deborah Hinnen
Diabetes Spectrum (2017) Vol. 30, Iss. 3, pp. 202-210
Open Access | Times Cited: 313
Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial
Houssam Halawi, Disha Khemani, Deborah J. Eckert, et al.
˜The œLancet. Gastroenterology & hepatology (2017) Vol. 2, Iss. 12, pp. 890-899
Closed Access | Times Cited: 175
Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity
Daniel B. Maselli, Michael Camilleri
Advances in experimental medicine and biology (2020), pp. 171-192
Closed Access | Times Cited: 141
Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
Andrés Acosta, Michael Camilleri, Barham Abu Dayyeh, et al.
Obesity (2021) Vol. 29, Iss. 4, pp. 662-671
Open Access | Times Cited: 124
The Efficacy of GLP-1 Analogues on Appetite Parameters, Gastric Emptying, Food Preference and Taste Among Adults with Obesity: Systematic Review of Randomized Controlled Trials
Malikah Aldawsari, Fatima A Almadani, Nujud Almuhammadi, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 575-595
Open Access | Times Cited: 47
Quantified Metrics of Gastric Emptying Delay by Glucagon-Like Peptide-1 Agonists: A Systematic Review and Meta-Analysis With Insights for Periprocedural Management
Brent Hiramoto, Thomas R. McCarty, Nayna A. Lodhia, et al.
The American Journal of Gastroenterology (2024) Vol. 119, Iss. 6, pp. 1126-1140
Closed Access | Times Cited: 25
Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
Camille Lupiañez-Merly, Saam Dilmaghani, Kia Vosoughi, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 4, pp. 475-491
Closed Access | Times Cited: 18
Glucagon‐like peptide‐1 receptor agonists: a narrative review of clinical pharmacology and implications for peri‐operative practice
David A. Milder, Tamara Y. Milder, S. Liang, et al.
Anaesthesia (2024) Vol. 79, Iss. 7, pp. 735-747
Open Access | Times Cited: 16
White Paper AGA: POWER — Practice Guide on Obesity and Weight Management, Education, and Resources
Andrés Acosta, Sarah E. Streett, Mathew D. Kroh, et al.
Clinical Gastroenterology and Hepatology (2017) Vol. 15, Iss. 5, pp. 631-649.e10
Closed Access | Times Cited: 152
Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: Results of a prospective study
Victoria Gómez, George Woodman, Barham K. Abu Dayyeh
Obesity (2016) Vol. 24, Iss. 9, pp. 1849-1853
Open Access | Times Cited: 103
Gastrointestinal hormones and regulation of gastric emptying
Michael Camilleri
Current Opinion in Endocrinology Diabetes and Obesity (2018) Vol. 26, Iss. 1, pp. 3-10
Open Access | Times Cited: 91
The novel dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 (GLP‐1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long‐acting GLP‐1 receptor agonists
Shweta Urva, Tamer Coşkun, Corina Loghin, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 10, pp. 1886-1891
Open Access | Times Cited: 83
The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials
Yupeng Liu, Binye Ruan, Huinan Jiang, et al.
American Journal of Clinical Nutrition (2023) Vol. 118, Iss. 3, pp. 614-626
Open Access | Times Cited: 37
Glucagon-Like Peptide-1 Agonists and General Anesthesia: Perioperative Considerations and the Utility of Gastric Ultrasound
Conner M Willson, L. Patel, Peter G. Middleton, et al.
Cureus (2024)
Open Access | Times Cited: 9
The novel GIP, GLP‐1 and glucagon receptor agonist retatrutide delays gastric emptying
Shweta Urva, Libbey S. O’Farrell, Yu Du, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 9, pp. 2784-2788
Open Access | Times Cited: 17
Perioperative Management of Patients Taking Glucagon-like Peptide-1 Receptor Agonists: Applying Evidence to Clinical Practice
Adriana D. Oprea, Guillermo E. Umpierrez, BobbieJean Sweitzer, et al.
Anesthesiology (2024) Vol. 141, Iss. 6, pp. 1141-1161
Closed Access | Times Cited: 6
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
Bianca Hemmingsen, David P. Sonne, Maria‐Inti Metzendorf, et al.
Cochrane library (2017) Vol. 2017, Iss. 5
Open Access | Times Cited: 55
Gastric Sensory and Motor Functions and Energy Intake in Health and Obesity—Therapeutic Implications
Lizeth Cifuentes, Michael Camilleri, Andrés Acosta
Nutrients (2021) Vol. 13, Iss. 4, pp. 1158-1158
Open Access | Times Cited: 34
Precision Medicine and Obesity
Maria D. Hurtado, Andrés Acosta
Gastroenterology Clinics of North America (2021) Vol. 50, Iss. 1, pp. 127-139
Open Access | Times Cited: 33
American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors
Reem Z. Sharaiha, Alpana P. Shukla, Sudipta Sen, et al.
Gastrointestinal Endoscopy (2025) Vol. 101, Iss. 2, pp. 285-294
Open Access
Allelic variant in the glucagon‐like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study
Victor Chedid, Prakhar Vijayvargiya, Paula Carlson, et al.
Neurogastroenterology & Motility (2018) Vol. 30, Iss. 7
Open Access | Times Cited: 46
Diabetic Gastroparesis and Glycaemic Control
Ryan J. Jalleh, Chinmay S. Marathe, Christopher K. Rayner, et al.
Current Diabetes Reports (2019) Vol. 19, Iss. 12
Closed Access | Times Cited: 35
Newer pharmacological interventions directed at gut hormones for obesity
Michael Camilleri, Andrés Acosta
British Journal of Pharmacology (2023) Vol. 181, Iss. 8, pp. 1153-1164
Closed Access | Times Cited: 12
A Systematic Review on Participant Diversity in Clinical Trials—Have We Made Progress for the Management of Obesity and Its Metabolic Sequelae in Diet, Drug, and Surgical Trials
Crystal Johnson-Mann, Julie S Cupka, Alexandra Ro, et al.
Journal of Racial and Ethnic Health Disparities (2022) Vol. 10, Iss. 6, pp. 3140-3149
Open Access | Times Cited: 18
Effects of GLP-1 and Other Gut Hormone Receptors on the Gastrointestinal Tract and Implications in Clinical Practice
Michael Camilleri, Camille Lupiañez-Merly
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 6, pp. 1028-1037
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top